Compare Incyte Corporation (INCY) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs IAC/Interactivecorp — how do they compare? Incyte Corporation trades at $120.45 (market cap $24.54B), while IAC/Interactivecorp trades at $40.35 (market cap $2.97B). The key difference: Incyte Corporation is far larger — about 8.3× IAC/Interactivecorp's market cap, and Incyte Corporation is trading nearer its 52-week high, IAC/Interactivecorp nearer its low. Which is the better fit depends on your goals.
| INCY | PPLI | |
|---|---|---|
Market Cap | $24.54B | $2.97B |
Sector | Health | Media |
52-Week High | $129.93 | $47.62 |
52-Week Low | $81.61 | $31.52 |
Enterprise Value | $20.04B | $3.28B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
